Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs AHBARx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and AHBARx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 112 · Grade C

AHBARx

Visit AHBARx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 73 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make AHBARx a bad call — it's best for readers who want published one-, three- and six-month options and will confirm that no separate membership charge applies. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
79
Transparency
90
94
Access Breadth
93
90
Clinical Oversight
92
72
Track Record
88
55
CoreAge RxBrief Score 94 · 73AHBARx

Price, coverage & the tracker

CoreAge RxAHBARx
Brief Score94/100 (A)73/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm membership charges

Semaglutide: $249 for one month; $649 upfront for three months or $1,199 for six. Separate membership terms conflict with no-fee messaging.

Full price details

Complete quote unknown because membership terms conflict; compounded semaglutide advertised $249/month, $649 upfront for 3 months or $1,199 for 6 months

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm membership charges

Tirzepatide: $349 for one month; $949 upfront for three months or $1,799 for six. Confirm whether a separate membership applies.

Full price details

Complete quote unknown because membership terms conflict; compounded tirzepatide advertised $349/month, $949 upfront for 3 months or $1,799 for 6 months

CoverageUS only; restrictions by state, confirmed at intakeUS patient location required; confirm state-specific clinician and pharmacy availability
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

AHBARx: Medication pages show $249 semaglutide and $349 tirzepatide monthly. Confirm the complete total: general terms also describe a separate weight-loss membership.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.